PCT & Support

Enclomiphene 25 mg Qimico

Qimico

60,00

In Stock (100 available)

Enclomiphene 25 mg Qimico (25 mg) — Backed by Qimico’s commitment to quality, the cornerstone of post-cycle therapy, essential for restoring the Hypothalamic-Pituitar…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost
Categories: ,

Description

Enclomiphene 25 mg Qimico — clomiphene from Qimico at 25 mg. SERM for PCT. Hypothalamic ER antagonism triggers GnRHLH/FSH release, restoring testicular testosterone production.

Key Benefits

  • SERM — primary PCT compound for LH/FSH recovery
  • Stronger LH stimulation than tamoxifen
  • Can be run solo for PCT or stacked with Nolvadex
  • Mood / vision side-effects common at high doses
  • Standard PCT 50 mg/day for 4 weeks, taper possible
  • Each unit dosed at 25 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: PCT 50 mg/day for 2 weeks, then 25 mg/day for 2 weeks. Some protocols start at 100 mg/day for week 1 then drop. Less commonly used on-cycle (Nolva preferred for gyno prevention).

How It Works

Selective estrogen receptor modulator. Antagonises estrogen at the hypothalamus, which upregulates GnRH → LH → testicular testosterone output. Effective for restarting the HPTA after AAS-induced suppression.

Pharmacokinetics

Plasma half-life approximately 5 days. Once-daily dosing sufficient. Steady-state in 7–10 days.

Potential Side Effects

Mood effects (irritability, depression, emotional lability) in a subset of users — switch to Nolva if severe. Visual disturbances at high dose (blurring, aura) — reduce dose. Hot flashes and night sweats during initial titration.

Cycle & Stacking Guide

PCT workhorse. Standard: 50/50/25/25 mg/day over 4 weeks, starting 14 days post-last-long-ester injection. Often paired with Nolva 20 mg/day for dual SERM action.

Manufacturer Notes

Qimico is an independent producer in the research-compound market. Before first use, request the batch-specific Certificate of Analysis and confirm the vial’s tamper-evident seal is intact.

Storage & Handling

Store in the original blister or bottle at 15–25 °C, away from direct sunlight, heat, and humidity. Oral preparations lose potency faster if exposed to moisture; keep the desiccant (if included) with the tablets. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Enclomiphene 25 mg Qimico”

Your email address will not be published. Required fields are marked *